Enrollment options

Corneal Edema, Secondary to Drug-Eluting Glaucoma Implant

A patient patient presented with pain, redness and blurry vision in both eyes. On slit lamp initial exam, he was found to have inferior corneal edema. On gonioscopy, a light-colored implant was noted in the inferior angle of both eyes. This was consistent with a bimatoprost implantable drug delivery system. Specular microscopy identified cornea endothelial cell loss. Decision was made to explant the implants in both eyes. Multiple glaucoma drug implants are available as an option for reducing drop burden in patients with ocular surface or drop compliance challenges. These commercially available devices elute prostaglandin drugs and have been shown to improve intraocular pressure. However, numerous complications, including corneal decompensation, have been identified. These risk must be considered in any clinical decisions regarding procedural pharmaceuticals for glaucoma drugs. In our patient, the symptoms improved and the endothelial cell counts were also noted to improved after removal of the implants.

Presentation Date: 11/12/2026
Issue Date: 11/13/2026


Please log in or click on ENROLL ME to access this course.

Include in Catalogue?: No
Presenter(s): Matthew J. McSoley, MD, MPH
Faculty Discussant(s): Elena Bitrian, MD
Self enrollment (Student)
Self enrollment (Student)